Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rare Gastrointestinal Disorders”

106 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 106 results

Not applicableLooking for participantsNCT07072143
What this trial is testing

An International Study on Pediatric Patients With Rare Tumors.

Who this might be right for
Paraganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)+11 more
Azienda Ospedaliera di Padova 6,250
Early research (Phase 1)Study completedNCT00004842
What this trial is testing

Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis

Who this might be right for
Cholangitis, SclerosingLiver Cirrhosis, Biliary
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 22
Not applicableUnknownNCT05496933
What this trial is testing

Colombia National Porphyria Registry

Who this might be right for
Rare DiseasesPorphyrias
Fundación Grupo de Investigación en Cuidados Intensivos y Obstetricia 100
Early research (Phase 1)Study completedNCT00004806
What this trial is testing

Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University of Alabama at Birmingham 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT06638931
What this trial is testing

Agnostic Therapy in Rare Solid Tumors

Who this might be right for
Urachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more
Instituto do Cancer do Estado de São Paulo 28
Not applicableNot Yet RecruitingNCT07128966
What this trial is testing

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

Who this might be right for
HealthyLupusCeliac+3 more
Joined Bio 100,000
Testing effectiveness (Phase 2)Study completedNCT03636347
What this trial is testing

A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.

Who this might be right for
Alpha 1-Antitrypsin DeficiencyEmphysemaCOPD
Mereo BioPharma 99
Not applicableLooking for participantsNCT02906943
What this trial is testing

Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

Who this might be right for
Breast CancerLung CancerColorectal Cancer+8 more
University Health Network, Toronto 10,000
Large-scale testing (Phase 3)Study completedNCT00004804
What this trial is testing

Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C

Who this might be right for
Hepatitis C
National Center for Research Resources (NCRR) 57
Early research (Phase 1)Study completedNCT00004471
What this trial is testing

Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer

Who this might be right for
Cystic Fibrosis
University of Alabama at Birmingham 9
Testing effectiveness (Phase 2)Study completedNCT00004789
What this trial is testing

Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria

Who this might be right for
Porphyria
National Center for Research Resources (NCRR) 59
Not applicableStudy completedNCT00004697
What this trial is testing

Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition

Who this might be right for
Fatty Liver
University of Texas 15
Not applicableStudy completedNCT02067754
What this trial is testing

Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer

Who this might be right for
Gastric Cancer
Samsung Medical Center 396
Not applicableEnded earlyNCT00005098
What this trial is testing

Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
National Center for Research Resources (NCRR) 160
Testing effectiveness (Phase 2)Study completedNCT03679598
What this trial is testing

Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency

Who this might be right for
Alpha-1 Antitrypsin Deficiency (AATD)Pi*ZZ, Pi*SZ, Pi*Null, Another Rare Phenotype/Genotype Known to be Associated With Either Low or Functionally Impaired AAT Including F or I MutationsEmphysema or COPD
University of Alabama at Birmingham 63
Testing effectiveness (Phase 2)Study completedNCT01833832
What this trial is testing

Surgery and Heated Chemotherapy for Adrenocortical Carcinoma

Who this might be right for
Adrenocortical CarcinomaPeritoneal Carcinomatosis
National Cancer Institute (NCI) 11
Not applicableStudy completedNCT00004410
What this trial is testing

Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants

Who this might be right for
Cholestasis
Children's Hospital Medical Center, Cincinnati 50
Not applicableEnrolling By InvitationNCT06041906
What this trial is testing

International Registry of Congenital Portosystemic Shunt (IRCPSS)

Who this might be right for
Congenital Portosystemic ShuntCPSS (Congenital Portosystemic Shunt)
Prof. Valérie Mc Lin 500
Testing effectiveness (Phase 2)Study completedNCT00004762
What this trial is testing

Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis

Who this might be right for
Cholangitis, Sclerosing
National Center for Research Resources (NCRR) 5
Testing effectiveness (Phase 2)Study completedNCT02034110
What this trial is testing

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

Who this might be right for
Cancer
Novartis Pharmaceuticals 206
Load More Results